- Effects of Losartan Administration on Uric acid Transporters in Rat Kidney
-
Kim S, Lee CH, Kang CM, Kim GH
- KMID: 2012309
- J Korean Soc Hypertens.
- 2010 Jun;16(2):19-27.
BACKGROUND: Losartan, an angiotensin II receptor blockade, has been reported to decrease the serum uric acid level through its uricosuric action. However, the mechanism by which losartan affects renal handling... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-Term Survival Following Port-Site Metastasectomy in a Patient with Laparoscopic Gastrectomy for Gastric Cancer: A Case Report
-
Kim SH, Kim DJ, Kim W
- KMID: 2372207
- J Gastric Cancer.
- 2015 Sep;15(3):209-213.
- doi: 10.5230/jgc.2015.15.3.209
A 78-year-old man underwent laparoscopy-assisted total gastrectomy for gastric cancer (pT3N0M0). Multiple port sites were used, including a 10 mm port for a videoscope at the umbilical point and three... -
- CITED
-
- Close
- SHARE
-
- Close
- Two Cases of Lacrimal Drainage Obstruction Associated With S-1 Anticancer Treatment
-
Park JS, Ha SW, Lew H
- KMID: 2213626
- J Korean Ophthalmol Soc.
- 2010 Jun;51(6):890-894.
- doi: 10.3341/jkos.2010.51.6.890
PURPOSE: To report two cases of lacrimal drainage obstruction associated with the anticancer drug S-1 (tegafur, gimeracil, oteracil ; TS-1(R), Taiho Pharmaceutical, Japan). CASE SUMMARY: (Case 1) A 34-year-old male who... -
- CITED
-
- Close
- SHARE
-
- Close
- S-1 Monotherapy as a Neoadjuvant Treatment for Locally Advanced Gastric Cancer
-
Jung JY, Rha SY, Ahn JB, Yang WI, Noh SH, Chung HC, Jeung HC
- KMID: 1382660
- Korean J Intern Med.
- 2008 Mar;23(1):37-41.
- doi: 10.3904/kjim.2008.23.1.37
S-1, a novel oral fluoropyrimidine, is an effective therapeutic agent for gastric cancer. Herein, we report a case with locally advanced gastric cancer that achieved a curative resection after S-1... -
- CITED
-
- Close
- SHARE
-
- Close
